| Literature DB >> 32555219 |
Irina Midenfjord1, Annikka Polster1, Henrik Sjövall1, Peter Friberg2, Hans Törnblom1, Magnus Simrén3,4.
Abstract
Abnormal gut-brain interactions are common in irritable bowel syndrome (IBS), but the associations between neurophysiological measures and their relation to gastrointestinal (GI) symptoms are poorly understood. Our aim was to explore these relationships and define the most relevant neurophysiology measures for GI symptom severity in IBS. IBS patients underwent small intestinal motility (manometry; fasted and fed contraction frequency, phase III time) and secretion (transmural potential difference), rectal sensorimotor (barostat; sensory thresholds, tone response, compliance), autonomic nervous system (baroreceptor sensitivity and effectiveness), and colonic motor function (transit time) examinations. GI symptom severity (GSRS-IBS), and anxiety and depression (HAD) as a proxy measure of central nervous system (CNS) dysfunction, were assessed. In total 281 IBS patients (Rome II criteria) were included (74% females, median age 36 [interquartile range 28-50] years). Significant correlations between neurophysiology measures were stronger within, rather than between, different neurophysiological examinations. The strongest neurophysiology-symptom correlations occurred between a combination of CNS and visceral sensitivity parameters, and GSRS-IBS total score and pain domain (ρ = 0.40, p < 0.001, and ρ = 0.38, p < 0.001). Associations between GI symptoms in IBS and individual and combinations of neurophysiological factors occurred, primarily in CNS and visceral sensitivity measures, providing new insights into the clinical presentation of IBS.Entities:
Mesh:
Year: 2020 PMID: 32555219 PMCID: PMC7300023 DOI: 10.1038/s41598-020-66558-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of the IBS-patients.
| Characteristic | IBS patients (N = 281) | IBS-C(N = 55) | IBS-D(N = 95) | IBS-A(N = 70) | p-value |
|---|---|---|---|---|---|
| Age in years | 36 [28–50] | 36 [29–49] | 41 [28–53] | 35 [27–50] | 0.48 |
| Female sex | 74% | 78% | 73% | 76% | 1.0* |
| IBS subtypes | |||||
| IBS-C | 25% | ||||
| IBS-D | 43% | ||||
| IBS-A | 32% | ||||
| GSRS-IBS | |||||
| Pain syndrome | 4 [3–5] | 4 [3–5] | 4 [4–5] | 4 [3–5] | 0.15 |
| Bloating syndrome | 5 [3–6] | 5 [4–6] | 5 [3–6] | 5 [4–6] | 0.31 |
| Constipation syndrome | 3 [1–4] | 4 [3–5] | 2 [1–3] | 3 [1–4] | |
| Diarrhoea syndrome | 3 [3–5] | 3 [3–4] | 4 [3–5] | 3 [2–4] | |
| Satiety syndrome | 2 [1–3] | 2 [1–3] | 3 [2,3] | 2 [1–3] | 0.28 |
| Total | 3.5 [2.8–4.2] | 3.7 [3.1–4.4] | 3.7 [2.9–4.2] | 3.2 [2.7–4.1] | 0.07 |
| Anxiety (HAD-A) | 6 [4–10] | 6 [4–10] | 6 [4–12] | 6 [4–10] | 0.68 |
| Depression (HAD-D) | 4 [2–7] | 4 [2–8] | 5 [2–8] | 4 [2–6] | 0.31 |
Presented as proportions (%) or as median with interquartile range. Differences between medians in the subgroups were analysed by Kruskal-Wallis tests or Chi squared test (marked with *). Significant p-values (p < 0.05) are marked in bold.
IBS: Irritable bowel syndrome; IBS-A: alternating IBS; IBS-C: constipation predominant IBS; IBS-D: diarrhoea predominant IBS; HAD-A: Hospital anxiety and depression scale, anxiety subscale; HAD-D: Hospital anxiety and depression scale, depression subscale.
Median values of the neurophysiological measures used in this study.
| Neurophysiological factor | Whole cohort | IBS-C | IBS-D | IBS-A | p-value |
|---|---|---|---|---|---|
| Central nervous system (N = 266) | |||||
| Psychological distress(HAD total score) | 11 [6–16] | 10 [7–16] | 12 [9–16] | 12 [6–16] | 0.58 |
| Colonic motility (N = 210) | |||||
| Colonic transit time(days) | 1.4 [1.0–2.1] | 2.1 [1.3–3.5] | 1.1 [0.7–1.7] | 1.5 [1.1–2.1] | |
| Rectal sensorimotor (N = 205) | |||||
| Early rectal tone response(%) | 31 [1.5–63] | 33 [7.1–57] | 30 [0.8–62] | 26 [−2.7–63] | 0.94 |
| Late rectal tone response(%) | 36 [1.1–80] | 35 [10–79] | 25 [−15–75] | 25 [−7.9–71] | 0.57 |
| Rectal dynamic compliance(ml mmHg−1) | 5.9 [4.2–8.2] | 5.9 [4.9–8.2] | 6.3 [4.1–8.5] | 6.2 [3.7–8.0] | 0.83 |
| Rectal static compliance(ml mmHg−1) | 8.4 [6.2–10] | 9.0 [6.6–10.4] | 7.9 [5.9–9.6] | 8.3 [6.1–10] | 0.60 |
| Rectal first sensation threshold(mmHg) | 7 [7–12] | 7 [7–12] | 7 [7–12] | 7 [7] | 0.07 |
| Rectal pain threshold(mmHg) | 32 [27–42] | 32 [26–45] | 31 [22–39] | 32 [27–42] | 0.20 |
| Small intestinal motility (N = 130) | |||||
| SI phase III time(s) | 477 [356–776] | 412 [358–694] | 659 [434–803] | 414 [305–569] | |
| SI fasted contraction frequency(minute−1) | 1.4 [1.1–1.9] | 1.4 [1.2–1.8] | 1.7 [1.3–2.0] | 1.4 [1.1–1.6] | 0.06 |
| SI fed contraction frequency(minute−1) | 2.9 [2.4–3.4] | 3.1 [2.6–3.4] | 2.8 [2.4–3.5] | 2.7 [2.3–3.5] | 0.64 |
| Small intestinal secretion (N = 130) | |||||
| SI potential difference, mean(mV) | −0.31 [−0.77–0.23] | −0.31 [−0.85–0.06] | −0.59 [−0.98–0.01] | −0.02 [−0.40–0.63] | |
| SI potential difference, max(mV) | −9.9 [−11–8.8] | −9.6 [−10–9.3] | −10 [−11–8.9] | −9.8 [−11–8.1] | 0.70 |
| SI potential difference, rate of rise (mV s−1) | −0.065 [−0.095–0.048] | −0.09 [−0.19–0.06] | −0.06 [−0.08–0.04] | −0.07 [−0.09–0.05] | 0.06 |
| Autonomic nervous system (N = 87) | |||||
| Baroreceptor sensitivity(ms mmHg−1) | 14 [10–19] | 11 [8–18] | 14 [10–19] | 13 [11–18] | 0.83 |
| Baroreceptor effectiveness | 0.36 [0.22–0.53] | 0.28 [0.22–0.50] | 0.35 [0.24–0.48] | 0.47 [0.19–0.57] | 0.54 |
Presented as medians with interquartile ranges. Number of patients completing the different neurophysiologic examinations are described in each heading. Differences between medians in the subgroups were analysed by Kruskal-Wallis tests. Significant p-values (p < 0.05) are marked in bold.
HAD: Hospital Anxiety and Depression scale; IQR: interquartile range; SI: small intestine/intestinal.
Figure 1Correlations between the neurophysiological factors from the overall cohort of IBS patients (N = 281). Significant correlations between neurophysiological factors are shown in the figure (p < 0.05, two-tailed, unadjusted for multiple comparisons). Numbers represent Spearman´s rho. Green edges show positive correlations, whereas red edges show negative correlations. BR: Baroreceptor; GSRS-IBS: Gastrointestinal Symptom Rating Scale, IBS version; HAD: Hospital Anxiety and Depression scale; SI: Small intestine/intestinal.
Neurophysiological factors in the models after Lasso regression.
| Neurophysiological factor | GSRS-IBS | |||||
|---|---|---|---|---|---|---|
| Pain | Bloating | Constipation | Diarrhoea | Satiety | Total | |
| HAD | X | X | X | X | X | X |
| Colonic transit time | X | X | ||||
| Early rectal tone response | ||||||
| Late rectal tone response | ||||||
| Rectal dynamic compliance | ||||||
| Rectal static compliance | ||||||
| Rectal first sensation threshold | X | |||||
| Rectal pain threshold | X | X | X | X | X | |
| SI phase III time | X | |||||
| SI fasted contraction frequency | X | |||||
| SI fed contraction frequency | ||||||
| SI potential difference, mean | X | X | X | |||
| SI potential difference, max | X | |||||
| SI potential difference, rate of rise | X | |||||
| Baroreceptor sensitivity | X | X | ||||
| Baroreceptor effectiveness | ||||||
| RMSE of Lasso score | 1.16 | 1.27 | 1.56 | 1.18 | 1.23 | 0.85 |
| Correlation with Lasso score | 0.38 | 0.20 | 0.14 | 0.29 | 0.29 | 0.40 |
Neurophysiological factors in the models after Lasso regression in GSRS-IBS total score and domain scores of GSRS-IBS. Lower RMSE indicates lower variability and thus better predictive ability of the model. Correlations are stated as Spearman’s rho. For comparison, the correlations with the overall neurophysiology score are included.
GSRS-IBS: Gastrointestinal Symptom rating scale, IBS version; HAD: Hospital Anxiety and Depression scale; Lasso: Least Absolute Selection and Shrinkage Operator regression; overall: Neurophysiology scores derived from all 16 neurophysiological factors; RMSE: Root Mean Square Error; pain threshold: pressure threshold for pain during the balloon distension test of rectal sensorimotor function; SI: small intestine/intestinal.
Figure 2Heatmap of correlations in the overall cohort of IBS patients (N = 281), between GSRS-IBS total score and domain scores of GSRS-IBS, and single neurophysiological factors, the overall neurophysiology scores, or the Lasso scores, respectively. The specified correlation coefficients and p values are available in Supplementary Table 1. BR: baroreceptor; GSRS-IBS: Gastrointestinal Symptom Rating Scale, IBS version; HAD: Hospital Anxiety and Depression scale; Lasso: Least Absolute Selection and Shrinkage Operator regression; overall: Neurophysiology scores derived from all 16 neurophysiological factors; PD; potential difference; SI: small intestine/intestinal.
Figure 3Comparisons of correlations between neurophysiology scores (overall neurophysiology score or Lasso scores) and GSRS-IBS total score and domain scores of GSRS-IBS in the overall cohort of IBS patients (N = 281). All correlations are significant (p < 0.05, two-tailed, false discovery rate adjusted for multiple comparisons), with the exceptions of Constipation - overall, Constipation – Lasso, Diarrhoea - overall and Satiety - overall. For specified p values, see Supplementary Table 1. GSRS-IBS: Gastrointestinal Symptom Rating Scale, IBS version; Lasso: Least Absolute Selection and Shrinkage Operator regression-derived neurophysiology scores; overall: Neurophysiology scores derived from all 16 neurophysiological factors.
Contribution of the neurophysiological factors to the overall neurophysiology score.
| Neurophysiologic factor | Low values | High values |
|---|---|---|
| HAD | − | + |
| Colonic transit time | + | + |
| Early rectal tone response | + | + |
| Late rectal tone response | + | + |
| Rectal dynamic compliance | + | + |
| Rectal static compliance | + | + |
| First sensation threshold | + | − |
| Pain threshold | + | − |
| SI phase III time | + | + |
| SI fasted contraction frequency | + | + |
| SI fed contraction frequency | + | + |
| SI potential difference, mean | − | + |
| SI potential difference, max | − | + |
| SI potential difference, rate of rise | − | + |
| Baroreceptor sensitivity | + | − |
| Baroreceptor effectiveness | + | − |
+:Increases the neurophysiology score; −: decreases the neurophysiology score; HAD: Hospital Anxiety and Depression scale; High values: >0 in z-score; Low values: <0 in z-score; SI: small intestine/intestinal.